| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 990925 | Value in Health Regional Issues | 2013 | 8 Pages |
Abstract
PP-LAI dominated the other drugs because it had the lowest cost and best clinical outcomes. Compared with depots of olanzapine and risperidone and oral olanzapine, PP-LAI was the cost-effective atypical LAI for treating chronic schizophrenia in Croatia. Using depot paliperidone in place of either olanzapine or risperidone would reduce the overall costs of caring for these patients.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Vlado MD, PhD, Miro MD, PhD, Igor MD, PhD, Miroslav MD, PhD, Ante MD, PhD, Tatjana MD, Roman MSc, Rasmus C.D. MSc, Michiel E.H. MSc, MBA, Thomas R. PhD,